Literature DB >> 29129566

Pediatric glioblastoma cells inhibit neurogenesis and promote astrogenesis, phenotypic transformation and migration of human neural progenitor cells within cocultures.

Kurt Farrell1, Gautam Mahajan1, Parthasarathy Srinivasan2, Moo-Yeal Lee1, Chandrasekhar R Kothapalli3.   

Abstract

Neural progenitor cell (NPC) fate is influenced by a variety of biological cues elicited from the surrounding microenvironment and recent studies suggest their possible role in pediatric glioblastoma multiforme (GBM) development. Since a few GBM cells also display NPC characteristics, it is not clear whether NPCs transform to tumor cell phenotype leading to the onset of GBM formation, or NPCs migrate to developing tumor sites in response to paracrine signaling from GBM cells. Elucidating the paracrine interactions between GBM cells and NPCs in vivo is challenging due to the inherent complexity of the CNS. Here, we investigated the interactions between human NPCs (ReNcell) and human pediatric GBM-derived cells (SJ-GBM2) using a Transwell® coculture setup to assess the effects of GBM cells on ReNcells (cytokine and chemokine release, viability, phenotype, differentiation, migration). Standalone ReNcell or GBM cultures served as controls. Qualitative and quantitative results from ELISA®, Live/Dead® and BrdU assays, immunofluorescence labeling, western blot analysis, and scratch test suggests that although ReNcell viability remained unaffected in the presence of pediatric GBM cells, their morphology, phenotype, differentiation patterns, neurite outgrowth, migration patterns (average speed, distance, number of cells) and GSK-3β expression were significantly influenced. The cumulative distance migrated by the cells in each condition was fit to Furth's formula, derived formally from Ornstein-Uhlenbeck process. ReNcell differentiation into neural lineage was compromised and astrogenesis promoted within cocultures. Such coculture platform could be extended to identify the specific molecules contributing to the observed phenomena, to investigate whether NPCs could be transplanted to replace lesions of excised tumor sites, and to elucidate the underlying molecular pathways involved in GBM-NPC interactions within the tumor microenvironment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Differentiation; GSK-3β; Migration; Neural progenitor cells; Pediatric glioblastoma cells

Mesh:

Substances:

Year:  2017        PMID: 29129566      PMCID: PMC5741502          DOI: 10.1016/j.yexcr.2017.11.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  70 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.

Authors:  Min H Kang; Malcolm A Smith; Christopher L Morton; Nino Keshelava; Peter J Houghton; C Patrick Reynolds
Journal:  Pediatr Blood Cancer       Date:  2010-10-04       Impact factor: 3.167

Review 3.  Understanding the role of cytokines in Glioblastoma Multiforme pathogenesis.

Authors:  Vivian F Zhu; Jingxuan Yang; Drake G Lebrun; Min Li
Journal:  Cancer Lett       Date:  2011-11-07       Impact factor: 8.679

4.  In vitro identification and functional characterization of glial precursor cells in human gliomas.

Authors:  C Colin; N Baeza; S Tong; C Bouvier; B Quilichini; P Durbec; D Figarella-Branger
Journal:  Neuropathol Appl Neurobiol       Date:  2006-04       Impact factor: 8.090

Review 5.  Interleukins in glioblastoma pathophysiology: implications for therapy.

Authors:  Y T Yeung; K L McDonald; T Grewal; L Munoz
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

6.  Detection of tumor stem cell markers in pancreatic carcinoma cell lines.

Authors:  Monika Olempska; Patricia Alice Eisenach; Ole Ammerpohl; Hendrik Ungefroren; Fred Fandrich; Holger Kalthoff
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-02

7.  Assessment of brain tumor cell motility in vivo and in vitro.

Authors:  M R Chicoine; D L Silbergeld
Journal:  J Neurosurg       Date:  1995-04       Impact factor: 5.115

Review 8.  CD133: molecule of the moment.

Authors:  D Mizrak; M Brittan; M R Alison
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

9.  The influence of fiber diameter of electrospun substrates on neural stem cell differentiation and proliferation.

Authors:  Gregory T Christopherson; Hongjun Song; Hai-Quan Mao
Journal:  Biomaterials       Date:  2008-10-31       Impact factor: 12.479

10.  Differential development of neuronal physiological responsiveness in two human neural stem cell lines.

Authors:  Roberta Donato; Erik A Miljan; Susan J Hines; Sihem Aouabdi; Kenneth Pollock; Sara Patel; Frances A Edwards; John D Sinden
Journal:  BMC Neurosci       Date:  2007-05-25       Impact factor: 3.288

View more
  4 in total

Review 1.  Pediatric glioblastoma: mechanisms of immune evasion and potential therapeutic opportunities.

Authors:  Rosy Njonkou; Christopher M Jackson; Graeme F Woodworth; David S Hersh
Journal:  Cancer Immunol Immunother       Date:  2022-01-12       Impact factor: 6.630

Review 2.  Biomaterials and 3D Bioprinting Strategies to Model Glioblastoma and the Blood-Brain Barrier.

Authors:  Min Tang; Jeremy N Rich; Shaochen Chen
Journal:  Adv Mater       Date:  2020-12-16       Impact factor: 30.849

3.  Extracellular vesicle-mediated amyloid transfer to neural progenitor cells: implications for RAGE and HIV infection.

Authors:  Ibolya E András; Marta Garcia-Contreras; Christopher Yanick; Paola Perez; Brice Sewell; Leonardo Durand; Michal Toborek
Journal:  Mol Brain       Date:  2020-02-17       Impact factor: 4.041

Review 4.  Advanced Spheroid, Tumouroid and 3D Bioprinted In-Vitro Models of Adult and Paediatric Glioblastoma.

Authors:  Louise Orcheston-Findlay; Samuel Bax; Robert Utama; Martin Engel; Dinisha Govender; Geraldine O'Neill
Journal:  Int J Mol Sci       Date:  2021-03-15       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.